126 related articles for article (PubMed ID: 30538383)
1. P-Glycoprotein Expression in Indian Breast Cancer Patients with Reference to Molecular Subtypes and Response to Anthracycline-Based Chemotherapy-a Prospective Clinical Study from a Developing Country.
Mehrotra M; Anand A; Singh KR; Kumar S; Husain N; Sonkar AA
Indian J Surg Oncol; 2018 Dec; 9(4):524-529. PubMed ID: 30538383
[TBL] [Abstract][Full Text] [Related]
2. Role of p-glycoprotein expression in predicting response to neoadjuvant chemotherapy in breast cancer--a prospective clinical study.
Chintamani ; Singh JP; Mittal MK; Saxena S; Bansal A; Bhatia A; Kulshreshtha P
World J Surg Oncol; 2005 Sep; 3():61. PubMed ID: 16164742
[TBL] [Abstract][Full Text] [Related]
3. Alteration in steroid hormone and Her-2/neu receptor status following neoadjuvant chemotherapy in locally advanced breast cancer: Experience at a tertiary care centre in India.
Ramteke P; Seenu V; Prashad R; Gupta SD; Iyer V; Deo S; Gogia A; Mathur S
Indian J Cancer; 2016; 53(3):366-371. PubMed ID: 28244460
[TBL] [Abstract][Full Text] [Related]
4. Molecular Subtypes As Emerging Predictors of Clinicopathological Response to Neoadjuvant Chemotherapy (NACT) in Locally Advanced Breast Cancer (LABC): A Single-Centre Experience in Western India.
Sharma S; Rathore SS; Verma V; Kalyan M; Singh N; Irshad I
Cureus; 2022 May; 14(5):e25229. PubMed ID: 35755569
[TBL] [Abstract][Full Text] [Related]
5. The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients.
Stamatovic L; Susnjar S; Gavrilovic D; Minic I; Ursulovic T; Dzodic R
J BUON; 2018; 23(5):1273-1280. PubMed ID: 30570847
[TBL] [Abstract][Full Text] [Related]
6. P-glycoprotein expression as a predictor of response to neoadjuvant chemotherapy in breast cancer.
Vishnukumar S; Umamaheswaran G; Anichavezhi D; Indumathy S; Adithan C; Srinivasan K; Kadambari D
Indian J Cancer; 2013; 50(3):195-9. PubMed ID: 24061458
[TBL] [Abstract][Full Text] [Related]
7. Outcome of neoadjuvant chemotherapy in locally advanced breast cancer: A tertiary care centre experience.
Bhattacharyya T; Sharma SC; Yadav BS; Singh R; Singh G
Indian J Med Paediatr Oncol; 2014 Jul; 35(3):215-20. PubMed ID: 25336793
[TBL] [Abstract][Full Text] [Related]
8. Correlation of clinicopathological outcomes with changes in IHC4 status after NACT in locally advanced breast cancers: do pre-NACT ER/PR status act as better prognosticators?
Chatterjee S; Saha A; Arun I; Nayak SS; Sinha S; Agrawal S; Parihar M; Ahmed R
Breast Cancer (Dove Med Press); 2015; 7():381-8. PubMed ID: 26677343
[TBL] [Abstract][Full Text] [Related]
9. Progesterone Receptors, Pathological Complete Response and Early Outcome for Locally Advanced Breast Cancer - a Single Centre Study. (PPLB - 01).
Agrawal S; Banswal L; Saha A; Arun I; Datta SS; Chatterjee S; Ahmed R
Indian J Surg Oncol; 2016 Dec; 7(4):397-406. PubMed ID: 27872526
[TBL] [Abstract][Full Text] [Related]
10. Expression of multidrug resistance proteins P-glycoprotein, multidrug resistance protein 1, breast cancer resistance protein and lung resistance related protein in locally advanced bladder cancer treated with neoadjuvant chemotherapy: biological and clinical implications.
Diestra JE; Condom E; Del Muro XG; Scheffer GL; Pérez J; Zurita AJ; Muñoz-Seguí J; Vigués F; Scheper RJ; Capellá G; Germà-Lluch JR; Izquierdo MA
J Urol; 2003 Oct; 170(4 Pt 1):1383-7. PubMed ID: 14501774
[TBL] [Abstract][Full Text] [Related]
11. In vivo detection of resistance to anthracycline based neoadjuvant chemotherapy in locally advanced and inflammatory breast cancer with technetium-99m sestamibi scintimammography.
Mezi S; Primi F; Capoccetti F; Scopinaro F; Modesti M; Schillaci O
Int J Oncol; 2003 Jun; 22(6):1233-40. PubMed ID: 12738988
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic alterations in breast cancer associated with neoadjuvant chemotherapy: A comparison with baseline rates of change.
Hariri N; Roma AA; Hasteh F; Walavalkar V; Fadare O
Ann Diagn Pathol; 2017 Dec; 31():14-19. PubMed ID: 29146052
[TBL] [Abstract][Full Text] [Related]
13. Discordance of Estrogen & Progesterone Receptors After Neoadjuvant Chemotherapy in Breast Cancer- an Indian Study.
Anand AS; Velayudhan ST
Indian J Surg Oncol; 2016 Sep; 7(3):316-9. PubMed ID: 27651692
[TBL] [Abstract][Full Text] [Related]
14. Expression of vascular endothelial growth factor and proliferation marker MIB1 are influenced by neoadjuvant chemotherapy in locally advanced breast cancer.
Singh M; Capocelli KE; Marks JL; Schleicher RB; Finlayson CA; Seligman PA
Appl Immunohistochem Mol Morphol; 2005 Jun; 13(2):147-56. PubMed ID: 15894927
[TBL] [Abstract][Full Text] [Related]
15. Proliferation rate and breast cancer subtype, but not ALDH1 expression, predict pathological response to neoadjuvant chemotherapy in locally advanced breast cancer.
Chatterjee D; Bal A; Das A; Singh G
Virchows Arch; 2015 Sep; 467(3):303-10. PubMed ID: 26063415
[TBL] [Abstract][Full Text] [Related]
16. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
17. A Multicenter Study of the Impact of Body Mass Index (BMI) on the incidence of Pathologic Complete Response (pCR) Among Saudi Patients with locally advanced Breast cancer (LABC) post Neoadjuvant Chemotherapy (NAC).
Al-Saleh K; Abd El-Aziz N; Ali A; Abo Zeed W; Salah T; Elsamany S; Rasmy A; El Farargy O; Husain S; Al-Rikabi A; Alsaeed E; Aldiab A; Abd El-Warith A
Gulf J Oncolog; 2019 May; 1(30):33-42. PubMed ID: 31242980
[TBL] [Abstract][Full Text] [Related]
18. Role of Tc99m-Sestamibi scintimammography in assessing response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
Mittal BR; Singh RK; Kumari S; Manohar K; Bhattacharya A; Singh G
Indian J Nucl Med; 2012 Oct; 27(4):221-5. PubMed ID: 24019650
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemotherapy-induced changes in immunohistochemical expression of estrogen receptor, progesterone receptor, HER2, and Ki-67 in patients with breast cancer.
Avci N; Deligonul A; Tolunay S; Cubukcu E; Fatih Olmez O; Ulas A; Hartavi M; Kurt E; Evrensel T
J BUON; 2015; 20(1):45-9. PubMed ID: 25778295
[TBL] [Abstract][Full Text] [Related]
20. Surgical Outcomes of Primary Versus Post-Neoadjuvant Chemotherapy Breast Conservation Surgery: A Comparative Study from a Developing Country.
Agarwal G; Sonthineni C; Mayilvaganan S; Mishra A; Lal P; Agrawal V
World J Surg; 2018 May; 42(5):1364-1374. PubMed ID: 29349483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
